CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBF) was the recipient of a significant drop in short interest in the month of August. As of August 31st, there was short interest totalling 1,027,400 shares, a drop of 11.2% from the August 15th total of 1,157,000 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 10,274.0 days.

CanSino Biologics Price Performance

CASBF stock remained flat at C$2.52 during midday trading on Wednesday. The company had a trading volume of 10 shares, compared to its average volume of 1,593. CanSino Biologics has a 52-week low of C$1.86 and a 52-week high of C$3.55. The stock’s 50 day simple moving average is C$2.26 and its 200-day simple moving average is C$2.27.

About CanSino Biologics

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.